Development of a Nomogram for Estimating the Risk of Left Ventricular Diastolic Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2022 Jun 16

PMID 35706476

Authors

Jinying Xia

Jianhui Li

Guang Jin

Danzhen Yao

Qifeng Hua

Affiliations

Soon will be listed here.

Abstract

Background: Patients with non-alcoholic fatty liver disease (NAFLD) are more likely to develop left ventricular diastolic dysfunction (LVDD). Although lifestyle adjustments contribute to the improvement of NAFLD, thereby delaying or even preventing LVDD progression, it is difficult to maintain a healthy lifestyle, resulting in a higher incidence of LVDD in NAFLD patients.

Objective: This study aims to develop a nomogram for assessing the risk of LVDD progression in NAFLD patients to increase their adherence to therapeutic interventions and adjust their treatment regimens timely.

Methods: A total of 148 medical records of NAFLD patients were retrospectively analyzed. Sixty-three were assigned to the LVDD+ group and 85 were assigned to the LVDD- group. The independent correlates of LVDD, which were screened via least absolute shrinkage and selection operator logistic regression model first, followed by multivariate Logistic regression model, constituted the nomogram to determine the likelihood of LVDD in NAFLD patients.

Results: Number of comorbidities, glycosylated hemoglobin, and epicardial adipose tissue (EAT) volume index were independent correlates of LVDD (all < 0.05). They served as components in the newly developed nomogram. It obtained significant clinical benefit in detecting NAFLD patients at the risk of LVDD progression, with satisfied discrimination and calibration.

Conclusion: We developed a nomogram for identifying NAFLD patients with a normal diastolic function who are at risk of LVDD progression, thus contributing to effective prevention of LVDD progression.

References

Luaces M, Cachofeiro V, Garcia-Munoz-Najar A, Medina M, Gonzalez N, Cancer E . Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol (Engl Ed). 2011; 65(1):14-21. DOI: 10.1016/j.recesp.2011.06.018. View

Russo C, Jin Z, Homma S, Rundek T, Elkind M, Sacco R . Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol. 2011; 57(12):1368-74. PMC: 3077126. DOI: 10.1016/j.jacc.2010.10.042. View

Lonardo A, Sookoian S, Pirola C, Targher G . Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism. 2015; 65(8):1136-50. DOI: 10.1016/j.metabol.2015.09.017. View

Park H, Choi S, Kim M . Association of epicardial fat with left ventricular diastolic function in subjects with metabolic syndrome: assessment using 2-dimensional echocardiography. BMC Cardiovasc Disord. 2014; 14:3. PMC: 3890512. DOI: 10.1186/1471-2261-14-3. View

Newman J, Schwartzbard A, Weintraub H, Goldberg I, Berger J . Primary Prevention of Cardiovascular Disease in Diabetes Mellitus. J Am Coll Cardiol. 2017; 70(7):883-893. PMC: 5656394. DOI: 10.1016/j.jacc.2017.07.001. View

Rider O, Francis J, Ali M, Petersen S, Robinson M, Robson M . Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009; 54(8):718-26. DOI: 10.1016/j.jacc.2009.02.086. View

Byrne C, Targher G . NAFLD: a multisystem disease. J Hepatol. 2015; 62(1 Suppl):S47-64. DOI: 10.1016/j.jhep.2014.12.012. View

Nseir W, Hellou E, Assy N . Role of diet and lifestyle changes in nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(28):9338-44. PMC: 4110565. DOI: 10.3748/wjg.v20.i28.9338. View

Chalasani N, Younossi Z, Lavine J, Diehl A, Brunt E, Cusi K . The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55(6):2005-23. DOI: 10.1002/hep.25762. View

10.

Grigorescu E, Lacatusu C, Floria M, Mihai B, Cretu I, Sorodoc L . Left Ventricular Diastolic Dysfunction in Type 2 Diabetes-Progress and Perspectives. Diagnostics (Basel). 2019; 9(3). PMC: 6787758. DOI: 10.3390/diagnostics9030121. View

11.

Ansaldo A, Montecucco F, Sahebkar A, Dallegri F, Carbone F . Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol. 2018; 278:254-260. DOI: 10.1016/j.ijcard.2018.09.089. View

12.

Graner M, Nyman K, Siren R, Pentikainen M, Lundbom J, Hakkarainen A . Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circ Cardiovasc Imaging. 2015; 8(1). DOI: 10.1161/CIRCIMAGING.114.001979. View

13.

Ibrahim E, Dennison J, Frank L, Stojanovska J . Diastolic Cardiac Function by MRI-Imaging Capabilities and Clinical Applications. Tomography. 2021; 7(4):893-914. PMC: 8706325. DOI: 10.3390/tomography7040075. View

14.

Wong C, Ganesan A, Selvanayagam J . Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J. 2016; 38(17):1294-1302. DOI: 10.1093/eurheartj/ehw045. View

15.

Browning J, Szczepaniak L, Dobbins R, Nuremberg P, Horton J, Cohen J . Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004; 40(6):1387-95. DOI: 10.1002/hep.20466. View

16.

Wong C, OMoore-Sullivan T, Leano R, Byrne N, Beller E, Marwick T . Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004; 110(19):3081-7. DOI: 10.1161/01.CIR.0000147184.13872.0F. View

17.

Morbach C, Wanner C, Stork S . [Update on diastolic heart failure]. Inn Med (Heidelb). 2022; 63(7):798-804. DOI: 10.1007/s00108-022-01286-z. View

18.

Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P . Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of.... J Am Soc Echocardiogr. 2005; 18(12):1440-63. DOI: 10.1016/j.echo.2005.10.005. View

19.

Lohn M, Dubrovska G, Lauterbach B, Luft F, Gollasch M, Sharma A . Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002; 16(9):1057-63. DOI: 10.1096/fj.02-0024com. View

20.

Silberman G, Fan T, Liu H, Jiao Z, Xiao H, Lovelock J . Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation. 2010; 121(4):519-28. PMC: 2819317. DOI: 10.1161/CIRCULATIONAHA.109.883777. View